236 related articles for article (PubMed ID: 35110956)
1. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study.
Brisinda G; Chiarello MM; Crocco A; Adams NJ; Fransvea P; Vanella S
World J Gastroenterol; 2022 Jan; 28(3):381-398. PubMed ID: 35110956
[TBL] [Abstract][Full Text] [Related]
2. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2006; 53(69):389-94. PubMed ID: 16795979
[TBL] [Abstract][Full Text] [Related]
3. [Short-term efficacy evaluation of laparoscopic spleen-preserving splenic hilus lymphadenectomy and left epigastrium mesogastric excision for advanced proximal gastric cancer based on mesangial anatomy].
Zhang YF; Chen P; Sun JG; Fan XJ; Wang YM; Gao YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):177-182. PubMed ID: 32074799
[No Abstract] [Full Text] [Related]
4. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
5. Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes.
Olmi S; Giorgi R; Cioffi SPB; Uccelli M; Villa R; Ciccarese F; Scotto B; Castello G; Legnani G; Cesana G
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):278-285. PubMed ID: 29135363
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
7. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
10. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.
Roviello F; Marrelli D; Morgagni P; de Manzoni G; Di Leo A; Vindigni C; Saragoni L; Tomezzoli A; Kurihara H;
Ann Surg Oncol; 2002 Nov; 9(9):894-900. PubMed ID: 12417512
[TBL] [Abstract][Full Text] [Related]
11. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
[TBL] [Abstract][Full Text] [Related]
12. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
[TBL] [Abstract][Full Text] [Related]
13. Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer.
Díaz de Liaño A; Yárnoz C; Artieda C; Aguilar R; Viana S; Artajona A; Ortiz H
Clin Transl Oncol; 2009 Mar; 11(3):178-82. PubMed ID: 19293056
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
Roukos D; Schmidt-Mathiesen A; Encke A
Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
[TBL] [Abstract][Full Text] [Related]
15. [Early postoperative complications and risk factors in laparoscopic D2 radical gastrectomy for gastric cancer].
Cai M; Zeng XY; Xiong Z; Gao JB; Shuai XM; Cai KL; Wang JL; Wang Z; Zhang P; Liu XH; Bai J; Cheng J; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):742-747. PubMed ID: 31422612
[No Abstract] [Full Text] [Related]
16. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer.
Yang K; Cho M; Roh CK; Seo WJ; Choi S; Son T; Kim HI; Hyung WJ
Surg Endosc; 2019 Jul; 33(7):2357-2363. PubMed ID: 30945060
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy in patients with gastric cancer. A critical review.
Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
[TBL] [Abstract][Full Text] [Related]
18. [Stomach cancer: have changes in surgical strategy influenced the results? 20-year retrospective study].
Seulin P; Carrère N; Bloom E; Pradère B; Tap G; Gouzi JL
Ann Chir; 2000 Feb; 125(2):131-6. PubMed ID: 10998798
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
20. Complications of gastrectomy with lymphadenectomy in gastric cancer.
Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
